G A Bishop

Author PubWeight™ 128.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995 12.24
2 A simple, rapid method for the purification of poly A+ RNA. Biotechniques 1988 3.22
3 Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996 2.01
4 Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol 2001 1.85
5 The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev 1986 1.81
6 Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J Biol Chem 2000 1.70
7 A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 2001 1.61
8 Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response. Lancet 1984 1.57
9 Cord blood mononuclear cell cytokine responses in relation to maternal house dust mite allergen exposure. Clin Exp Allergy 2002 1.51
10 Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol 1997 1.50
11 Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 2001 1.48
12 Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc Natl Acad Sci U S A 1986 1.46
13 Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J Exp Med 1983 1.27
14 Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells. Eur J Immunol 1999 1.25
15 Automobile emissions are statistically gamma distributed. Environ Sci Technol 1994 1.24
16 Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology 1996 1.19
17 Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997 1.19
18 False detection of negative-strand hepatitis C virus RNA. Lancet 1994 1.18
19 Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J Immunol 1997 1.17
20 Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. J Virol 1986 1.16
21 Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation. J Immunol 1999 1.15
22 Different CD40-mediated signaling events require distinct CD40 structural features. J Immunol 1996 1.15
23 Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. J Immunol 1984 1.11
24 On-road vehicle emissions: regulations, costs, and benefits. Science 1995 1.11
25 Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev 2000 1.11
26 Oxygen binding constants for human hemoglobin tetramers. Biochemistry 1987 1.09
27 The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J Immunol 1999 1.08
28 Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation 1993 1.08
29 Cytokine profiles in spontaneously regressing basal cell carcinomas. Br J Dermatol 2000 1.05
30 Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J Immunol 2000 1.05
31 Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study. Brain Res 1980 1.04
32 Role of interferon in human natural killer activity against target cells infected with HSV-1. J Immunol 1983 1.04
33 Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology 1994 1.02
34 Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int 1986 1.01
35 Physiological and anatomical studies of the interactions between Purkinje cells and basket cells in the cat's cerebellar cortex: evidence for a unitary relationship. J Neurosci 1989 1.01
36 Sentinel skin allograft-a reliable marker for monitoring of composite tissue transplant rejection. Transplant Proc 2009 1.00
37 Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995 1.00
38 T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas. J Invest Dermatol 1997 0.99
39 CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J Immunol 1996 0.99
40 Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology 1997 0.98
41 Morphological and physiological properties of neostriatal neurons: an intracellular horseradish peroxidase study in the rat. Neuroscience 1982 0.97
42 Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation 1999 0.97
43 The distribution and origin of serotonin immunoreactivity in the rat cerebellum. Brain Res 1985 0.96
44 Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms. J Immunol 2001 0.95
45 Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J Immunol 1999 0.95
46 Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection. Transplantation 2000 0.95
47 H-2 control of expression of an idiotype shared by normal B cells and a B-cell lymphoma. Immunogenetics 1985 0.94
48 The use of electron microscopic immunocytochemistry with silver-enhanced 1.4-nm gold particles to localize GAD in the cerebellar nuclei. J Histochem Cytochem 1995 0.93
49 Morphological and electrophysiological characteristics of projection neurons in the nucleus interpositus of the cat cerebellum. J Comp Neurol 1978 0.92
50 Allele non-amplification: a source of confusion in linkage studies employing microsatellite polymorphisms. Hum Mol Genet 1993 0.91
51 IR long-path photometry: a remote sensing tool for automobile emissions. Anal Chem 1989 0.90
52 Differential structure-function requirements of the transmembranal domain of the B cell antigen receptor. J Exp Med 1992 0.89
53 Electrophysiological and horseradish peroxidase studies of precerebellar afferents to the nucleus interpositus anterior. II. Mossy fiber system. Brain Res 1977 0.89
54 Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: early activation and apoptosis is associated with liver graft acceptance. Transplantation 1998 0.88
55 Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon. Br J Pharmacol 2009 0.88
56 Signaling through MHC class II molecules blocks CD95-induced apoptosis. J Immunol 2001 0.88
57 High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein. Proc Natl Acad Sci U S A 1988 0.87
58 Enhancement of human natural killer cells by interferon requires RNA and protein synthesis. Clin Immunol Immunopathol 1982 0.87
59 Intracellular staining of Purkinje cells and their axons with horseradish peroxidase. Brain Res 1976 0.87
60 Expression of HLA antigens on renal tubular cells in culture. I. Evidence that mixed lymphocyte culture supernatants and gamma interferon increase both class I and class II HLA antigens. Transplantation 1986 0.86
61 Cutting edge: a novel mechanism for rescue of B cells from CD95/Fas-mediated apoptosis. J Immunol 1999 0.86
62 Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling. J Immunol 1993 0.85
63 Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation 1999 0.85
64 Electrophysiological and horseradish peroxidase studies of precerebellar afferents to the nucleus interpositus anterior. I. Climbing fiber system. Brain Res 1977 0.85
65 Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 1994 0.85
66 Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology 1993 0.85
67 A horseradish peroxidase study of the cortico-olivary projection in the cat. Brain Res 1976 0.84
68 Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance. Am J Transplant 2013 0.83
69 Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism. J Immunol 2001 0.83
70 Tolerance to rat liver allografts: IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation 1996 0.83
71 Induction of HLA-DR antigens on cultured human kidney cells. Transplant Proc 1986 0.82
72 An HRP and autoradiographic study of the projection from the cerebellar cortex to the nucleus interpositus anterior and nucleus interpositus posterior of the cat. J Comp Neurol 1979 0.81
73 A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling. Hepatology 1990 0.81
74 The cytoplasmic and transmembrane domains of MHC class II beta chains deliver distinct signals required for MHC class II-mediated B cell activation. Immunity 1995 0.81
75 Stimulation of the inferior olivary complex alters the distribution of the type 1 corticotropin releasing factor receptor in the adult rat cerebellar cortex. Neuroscience 2008 0.81
76 Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells. Kidney Int 1991 0.80
77 An enzyme-immunoassay for myoglobin in human serum and urine. Method development, normal values and application to acute myocardial infarction. Pathology 1979 0.80
78 Corticotropin releasing factor induces proliferation of cerebellar astrocytes. J Neurosci Res 2000 0.80
79 Time course of upregulation of fibrogenic growth factors and cellular infiltration in a rodent model of chronic renal allograft rejection. Transpl Immunol 2002 0.79
80 Topographical organization in the origin of serotoninergic projections to different regions of the cat cerebellar cortex. J Comp Neurol 1991 0.79
81 Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997 0.79
82 Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors. Med J Aust 1992 0.79
83 The synaptic features of horseradish peroxidase-labelled recurrent collaterals in the ganglionic plexus of the cat cerebellar cortex. J Neurocytol 1982 0.79
84 Frequency-dependent expression of corticotropin releasing factor in the rat's cerebellum. Neuroscience 2003 0.79
85 The physiological effects of serotonin are mediated by the 5HT1A receptor in the cat's cerebellar cortex. Brain Res 1992 0.79
86 Cell bodies of origin of serotonin-immunoreactive afferents to the inferior olivary complex of the rat. Brain Res 1986 0.79
87 An analysis of the morphology and cytology of HRP labeled Purkinje cells. Brain Res Bull 1981 0.79
88 Role of the interleukin 2 receptor in differentiation of a clone of Ly-1+ B cells. J Immunol 1987 0.79
89 Worldwide on-road vehicle exhaust emissions study by remote sensing. Environ Sci Technol 1995 0.79
90 An analysis of HRP-filled basket cell axons in the cat's cerebellum. II. Axonal distribution. Anat Embryol (Berl) 1993 0.79
91 The distribution of corticotropin-releasing factor (CRF), CRF binding sites and CRF1 receptor mRNA in the mouse cerebellum. Prog Brain Res 1997 0.79
92 Distribution of corticotropin-releasing factor in the cerebellum and precerebellar nuclei of the opossum: a study utilizing immunohistochemistry, in situ hybridization histochemistry, and receptor autoradiography. J Comp Neurol 1989 0.79
93 Altered zonal expression of the CD26 antigen (dipeptidyl peptidase IV) in human cirrhotic liver. Hepatology 1992 0.79
94 Presynaptic localization of a truncated isoform of the type 2 corticotropin releasing factor receptor in the cerebellum. Neuroscience 2006 0.78
95 Identification of the cellular subpopulations infiltrating rejecting cadaver renal allografts. Preponderance of the T4 subset of T cells. Transplantation 1984 0.78
96 Atherosclerosis of the liver allograft. J Hepatol 1997 0.78
97 Antigen-specific B cell tumors of mice. Crit Rev Immunol 1986 0.78
98 A quantitative analysis of the distribution of Purkinje cell axonal collaterals in different zones of the cat's cerebellum: an intracellular HRP study. Exp Brain Res 1990 0.78
99 Portal capillary destruction in liver allograft rejection. Transplant Proc 1992 0.78
100 Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia. Dis Nerv Syst 1977 0.78
101 Fine structural analysis of calcitonin gene-related peptide in the mouse inferior olivary complex. J Neurocytol 1999 0.78
102 Substance P and serotonin immunoreactivity in the rat inferior olive. Brain Res Bull 1984 0.77
103 Evidence for an axonal localization of the type 2 corticotropin-releasing factor receptor during postnatal development of the mouse cerebellum. Exp Neurol 2004 0.77
104 Diagnosis of renal allograft rejection by analysis of fine-needle aspiration biopsy specimens with immunostains and simple cytology. Lancet 1986 0.77
105 Levels of cytokine expression in rat liver allograft rejection compared to allograft tolerance. Transplant Proc 1992 0.77
106 Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation. Immunology 1998 0.77
107 Positive and negative regulation of Thy-1 expression on B lymphocytes by IL-4. Int Immunol 1995 0.77
108 Distribution and brainstem origin of cholecystokinin-like immunoreactivity in the opossum cerebellum. J Comp Neurol 1990 0.77
109 Keratoacanthomas have an immunosuppressive cytokine environment of increased IL-10 and decreased GM-CSF compared to squamous cell carcinomas. Br J Cancer 1999 0.77
110 The effect of ADP, calcium and some inhibitors of platelet aggregation on protein phosphokinases from human blood platelets. Biochim Biophys Acta 1975 0.77
111 Microchimerism and transplant tolerance. Immunol Today 1997 0.77
112 Ontogenesis of cerebellar afferents identified by cholecystokinin-like immunoreactivity. Brain Res Dev Brain Res 1992 0.77
113 The origin of serotoninergic afferents to the cat's cerebellar nuclei. J Comp Neurol 1994 0.77
114 Peptide localization in the mouse inferior olive. J Chem Neuroanat 1997 0.76
115 Peptides in cerebellar circuits. Prog Neurobiol 1992 0.76
116 The pattern of distribution of the local axonal collaterals of Purkinje cells in the intermediate cortex of the anterior lobe and paramedian lobule of the cat cerebellum. J Comp Neurol 1982 0.76
117 Localization of serotonin immunoreactivity in the opossum cerebellum. J Comp Neurol 1985 0.76
118 Anatomical evidence for enkephalin immunoreactive climbing fibres in the cerebellar cortex of the opossum. J Neurocytol 1986 0.76
119 Use of the CH lymphomas as models of murine B cell differentiation. Immunol Res 1986 0.76
120 Atopy, anergic status, and cytokine expression in HIV-infected subjects. J Allergy Clin Immunol 1999 0.76
121 Distribution of tyrosine hydroxylase-immunoreactive afferents to the cerebellum differs between species. J Comp Neurol 1997 0.76
122 The physiological effects of serotonin on spontaneous and amino acid-induced activation of cerebellar nuclear cells: an in vivo study in the cat. Prog Brain Res 1997 0.76
123 Dipeptidyl peptidase IV is down-regulated in rat hepatoma cells at the mRNA level. J Gastroenterol Hepatol 1993 0.75
124 Brainstem origin of serotonin- and enkephalin-immunoreactive afferents to the opossum's cerebellum. J Comp Neurol 1988 0.75
125 Effect of immunosuppressives on gamma-interferon production, lymphocyte proliferation, and cytotoxic function of activated T lymphocytes. Transplant Proc 1987 0.75
126 Improved nursing home care: desirable and possible. J Long Term Care Adm 1976 0.75
127 Role of the LFA-1 molecule in B cell differentiation. Curr Top Microbiol Immunol 1986 0.75
128 Heterogeneity in the pattern of distribution of the axonal collaterals of Purkinje cells in zone b of the cat's vermis: an intracellular HRP study. J Comp Neurol 1986 0.75
129 Use of monoclonal antibodies to study in vivo and in vitro-activated lymphocytes. Transplant Proc 1989 0.75
130 Experimental limb transplantation, part III: induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient. Transplant Proc 2004 0.75
131 Calorimetric studies of oxygen and carbon monoxide binding to human hemoglobin. Sequential binding heats for oxygen. J Biol Chem 1987 0.75
132 The site of origin of calcitonin gene-related peptide-like immunoreactive afferents to the inferior olivary complex of the mouse. Neurosci Res 1999 0.75
133 T cell subsets in fine needle aspiration biopsies from renal transplant recipients. Transplant Proc 1985 0.75
134 Development of the basilar pons in the North American opossum: dendrogenesis and maturation of afferent and efferent connections. Anat Embryol (Berl) 1987 0.75
135 Residential care facilities: to transfer or not? Nurs Homes 1968 0.75
136 Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival. Transplant Proc 2005 0.75
137 RPA-2.10: an anti-CD2 monoclonal antibody that inhibits alloimmune responses and monitors T cell activation. Transplant Proc 1987 0.75
138 Cell-mediated lympholysis: target susceptibility to lysis correlates with surface major histocompatibility complex expression. Transplant Proc 1987 0.75
139 An immunohistochemical study of serotonin development in the opossum cerebellum. Anat Embryol (Berl) 1985 0.75
140 Guest editorial: Long-term care's finest hour. J Long Term Care Adm 1976 0.75
141 Systemic immune response in rejection and tolerance of rat liver allografts. Transplant Proc 1995 0.75
142 Reticulo-olivary circuits: an intracellular HRP study in the rat. Brain Res 1986 0.75
143 Target susceptibility in cell-mediated lympholysis assays correlates with major histocompatibility complex surface antigen expression. Transplant Proc 1987 0.75
144 The importance of the ICAM-1/LFA-1-dependent pathway in in vitro cytotoxicity against cultured human kidney cells. Transplant Proc 1990 0.75
145 Donor leukocytes combined with delayed immunosupressive drug therapy prolong limb allograft survival. Transplant Proc 2005 0.75
146 Is the T helper 1/T helper 2 paradigm of allograft tolerance dead or has it just been turned upside down? Transplantation 1999 0.75
147 Structure function analysis of the H-2 Abp gene. Immunogenetics 1991 0.75
148 Defining the ICF. Nurs Homes 1971 0.75
149 Polymorphism in the beta chain of IAq versus IAp influences presentation of protein but not peptide antigens. Cell Immunol 1995 0.75
150 Quantitation of cytokine mRNA expression in biopsies from human liver allografts by a novel reverse transcriptase/polymerase chain reaction method. Transplant Proc 1995 0.75
151 Endogenous secretion of IL-4 maintains growth and Thy-1 expression of a transformed B cell clone. J Immunol 1993 0.75
152 Cyclosporine inhibition of CH series murine B-cell lymphomas. Cell Immunol 1987 0.75
153 The physiological effects of peptides and serotonin on Purkinje cell activity. Prog Neurobiol 1992 0.75
154 The origin of the reticulo-olivary projection in the rat: a retrograde horseradish peroxidase study. Neuroscience 1984 0.75